KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug ... ( NORTH LIBERTY Iowa Aug. 25 /- KemPhar...)

KemPharm, Inc. Receives Notice of Issuance from USPTO on Second Patent Protecting Company's ADHD Prodrug Technology

Date:8/25/2010

NORTH LIBERTY, Iowa, Aug. 25 /PRNewswire/ -- KemPharm, Inc. announced today that it has received a Notice of Issuance from the United States Patent and Trademark Office (USPTO) for its patent application entitled "Non-Standard Amino Acid Conjugates of Amphetamine and Processes for Making and Using the Same", U.S. Patent No. 7,776,917 B2. This patent, combined with KemPharm's recently issued U.S. Patent No. 7,772,222, provides broad protection of the Company's Ligand Activated Therapy (LAT) prodrug technology platform and its application to the treatment of Attention Deficit – Hyperactivity Disorder. The patent covers the Company's lead clinical candidate KP106, a new chemical entity (NCE) composed of the active pharmaceutical compound d-amphetamine and a ligand, which recently successfully completed a Phase 1 clinical trial.

"This second Notice of Issuance within a week of our first patent, reinforces our strong intellectual property position covering KP106 and other potential ADHD drugs derived from our LAT technology," stated Travis Mickle, Ph.D., President & CSO for KemPharm. "Our prodrug platform continues to deliver on all fronts in ADHD as well as other indications, and we are excited to secure the necessary protection that will allow us to fully develop and commercialize our discoveries."

"We have placed patent protection as a strategic priority from the inception of every program, so it is great to see that our efforts are being rewarded," added Sven Guenther, Ph.D., Vice President of Research. "The nature of LAT can lend itself to generating a wide range of prodrugs with diverse pharmacological and physicochemical properties that represent distinct and non-obvious changes from the parent drugs. These unique attributes enable us to pursue and receive protection from the USPTO."

About KP106KP106, KemPharm's lead prodrug candidate for the treatment of ADHD, is composed of d'/>"/>

SOURCE KemPharm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. KemPharm, Inc. Receives Notice of Issuance From USPTO on Patent Protecting Companys ADHD Prodrug Technology
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. CryoCor Receives FDA Approval for Right Atrial Flutter
8. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
9. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
10. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
11. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma

Post Your Comments:

(Date:5/20/2013)... LONDON , BERLIN and ... -- Arthroscopy Devices Market to 2018 ... Minimally Invasive Procedures to Drive Future Growth" looks at ... the six arthroscopy device market segments: arthroscopes, arthroscopy shavers, ... frequency systems, and arthroscopy visualization systems. The report provides ...

(Date:5/20/2013)... 2013 Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...

(Date:5/20/2013)... , May 20, 2013 With herbal ... resource available from the U.S. Pharmacopeial Convention (USP) will ... quality of the herbal ingredients used in these products. ... included in the new Herbal Medicines Compendium ... worldwide at hmc.usp.org . HMC ...

Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2 Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3 Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4 New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2 New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3

[0] Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth [0] Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania [0] New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines

... Reportlinker.com announces that a new market research report ... Nephrology and Urology Devices Market Outlook to 2017 ... and Urology Devices Market Outlook to 2017 ... Nephrology and Urology Devices Market Outlook to 2017" provides ...

... Reportlinker.com announces that a new market research ... Continuous Glucose Monitoring (CGM) Systems ... Market Forecasts to 2016 ... Monitoring (CGM) Systems - Global Pipeline Analysis, ...

Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 Reportlinker Adds Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

(Date:5/20/2013)... of Atlanta SEO company EverSpark Interactive, Jason ... International INVEST Domaining & Internet Marketing Conference in Mexico ... independent individuals from around the world to discuss the ... 2013 conference will take place at the Mexico City ... 21. A networking city tour day is on May ...

(Date:5/20/2013)... The Muscular Dystrophy Association ... bars for good at an Executive Lock-Up at Chima ... a.m. , More than 100 “jailbirds” are expected ... individuals and families affected by muscle disease. Representatives from ... celebrities, realtors, doctors, attorneys, bankers, and members of the ...

(Date:5/20/2013)... May 20, 2013 ... Who: Sloan Gibson, President, USO and CEO ... of Outreach Initiatives and Partners, Sesame ... , Representatives from:, ... • U.S. House ...

(Date:5/20/2013)... National law firm Parker Waichman LLP and ... P.A., both based in Little Rock, Arkansas – have filed ... billion settlement of a price-fixing case against Visa Inc. and ... Wednesday, May 15, 2013, in the U.S. District Court for ... Visa and MasterCard (Case No. 1:05-md-1720) is titled In Re: ...

(Date:5/20/2013)... York (PRWEB) May 20, 2013 The nationwide ... study has found that magnetic resonance imaging (MRI) can be ... of whether or not patients are experiencing symptoms. According ... Journal of Bone & Joint Surgery, MRI detected synovitis (tissue ... patients suffering symptoms due to mechanical causes, the detection rate ...

Breaking Medicine News(10 mins):Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2 Health News:MDA to Put Fort Lauderdale Community Leaders Behind Bars for Good 2 Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 2 Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 3 Health News:USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill 4 Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2 Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3 Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 2 Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 3 Health News:Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure 4

[0] EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City [0] MDA to Put Fort Lauderdale Community Leaders Behind Bars for Good [0] USO to Celebrate Five-Year Partnership of Sesame Street/USO Experience for Military Families at Biannual Care Package Service Project on Capitol Hill [0] Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’[0] Metal-on-Metal Hip Replacement Lawyers Note New Study Finding MRIs Can Be Used to Predict Metal-on-Metal Hip Implant Failure

... 1, 2012 A nutrient found in the dark meat ... in women with high cholesterol, according to a study by ... published online in the European Journal of Nutrition , ... the dark meat of turkey and chicken, as well as ...

... By Lisa Esposito HealthDay Reporter , THURSDAY, March 1 ... according to new research that challenges conventional wisdom that a good ... a survey of 150,000 adults, people in their 70s and 80s ... ages of 18 and 24 had the most. Except for a ...

... Reston, Va. (March 1, 2012) Imaging amino ... has been shown to significantly alter intended management ... research in the March issue of The ... of imaging with the radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-L-phenylalanine (F-18-DOPA), physicians ...

... , WEDNESDAY, Feb. 29 (HealthDay News) -- Two new ... with the rare bone marrow disorder called myelofibrosis. While ... name Jakafi, won,t cure myelofibrosis, it can help ease symptoms, ... the studies. "This is probably the most thrilling ...

... England Journal of Medicine shows that the 50 percent ... from the drug Vemurafenib increasing median survival from about ... drug stopped cancer progression for a median 6.7 months. ... is a breakthrough. Not a cure, but a major breakthrough," ...

... Orange, NJ -- Jordan Grafman, PhD, director of Traumatic Brain ... The 2nd Annual Traumatic Brain Injury Conference on March 6, ... long-term cognitive and social consequences of traumatic brain injury. A ... the influence of the location of brain injury and genetic ...

Cached Medicine News:Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 2 Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 3 Health News:Older Adults Do Get a Good Night's Rest, Survey Finds 2 Health News:Older Adults Do Get a Good Night's Rest, Survey Finds 3 Health News:PET tracer changes management plan for brain tumor patients 2 Health News:New Drug May Help Fight Rare Bone Marrow Disorder 2 Health News:New Drug May Help Fight Rare Bone Marrow Disorder 3 Health News:Kessler Foundation neuroscientist addresses 2nd Annual TBI Conference in Washington DC 2

Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits Older Adults Do Get a Good Night's Rest, Survey Finds PET tracer changes management plan for brain tumor patients New Drug May Help Fight Rare Bone Marrow Disorder New drug, Vemurafenib, doubles survival of metastatic melanoma patients Kessler Foundation neuroscientist addresses 2nd Annual TBI Conference in Washington DC

Designed to securely hold scleral plugs during insertion and removal. The cross action handle is designed to reduce hand fatigue while grasping plug....

Ergotec Vetriretinal Instrument System. Ultra-fine 3.35 mm jaws. Angled 55 degrees. 20 gauge shaft. 30 mm in length. Blackened tip. Overall length from rear rotation knob to tip....

Angled shafts with 12 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left. Most popular size or model....

Shafts angled 45 degrees, 10 mm from tip to bend. 1 x 2 teeth. Serrated handle with polished finish. Most popular size or model....

Medicine Products:

Scleral Plug Forceps Subretinal Forcep Black Long Jameson Muscle Forceps - Left Trouan Superior Rectus Forceps